Sign in
Taking peopleNo phase

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder

Key facts

Who runs it
Shanghai Mental Health Center
Where
China10 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
14 Dec 2024
Expected to end
31 Mar 2027
Type of study
Interventional, 3 groups
Treatments tested
  • deep brain stimulation
Record updated
3 July 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • aged 18-65 years old
  • a diagnosis of OCD based on The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)
  • the Y-BOCS total score ≥ 25
  • met the criteria of treatment refractory. Treatment refractory is defined as failed a) Inadequate response or intolerance to at least three adequate trials of selective serotonin reuptake inhibitors (SSRIs), combined with at least two second-generation antipsychotics as augmentation agents; Inadequate response or intolerance to cognitive behavioral therapy (CBT) consisting of more than 12 sessions conducted concurrently with adequate dosed SSRIs treatment

Who cannot take part

  • History of implantation of a cochlear implant, cardiac pacemaker, cardiac defibrillator, prior unilateral or bilateral implantation of similar devices, or other surgical procedures within the past six months that may affect study participation as judged by the investigator
  • Contraindications to DBS implantation or deemed unfit for surgery by the investigator
  • Participation in another drug or medical device clinical trial currently or within three months prior to screening
  • Presence of other psychiatric disorders such as organic mental disorders, paranoid personality disorder, or mental retardation
  • Presence of severe or unstable cardiovascular, respiratory, hepatic, renal, hematologic, endocrine, neurological, or other systemic diseases
  • History of organic brain disorders, traumatic brain injury, intractable epilepsy, or other neurological conditions
  • Confirmed HIV-positive status
  • Any other condition deemed by the investigator to render the individual unsuitable for the study
  • Clinically significant abnormalities in physical examination, laboratory tests, electrocardiogram, or imaging during screening or baseline that, in the investigator's judgment, make the individual unsuitable for the study
  • Individuals deemed by the investigator to be at significant risk of suicidal behavior based on clinical assessment
  • Pregnant or breastfeeding women, women of childbearing potential with positive blood/urine HCG results at screening, those unable to use effective contraception during the study, or those planning to conceive within three months after study initiation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc) deep brain stimulation (DBS) in patients with treatment-refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer is:

Read full original descriptionShow less

Does the timing of DBS activation (at 1, 2, or 3 months post-surgery) affect the reduction rate in Y-BOCS scores? Researchers will compare three groups-DBS activated at 1, 2, and 3 months post-surgery-to determine whether earlier or later stimulation leads to greater symptom improvement.

Participants will:

* Undergo surgical implantation of an intracranial neurostimulation system targeting ALIC-NAc * Be randomly assigned to one of three DBS activation timing groups * Receive regular clinical assessments over a 6-month follow-up period after activation

The 3 groups in the trial

  • one-month groupTreatment being tested

    DBS activation at 30 ± 7 days post-surgery

    Treatment: deep brain stimulation

  • two-month groupTreatment being tested

    DBS activation at 60 ± 7 days post-surgery

    Treatment: deep brain stimulation

  • three-month groupTreatment being tested

    DBS activation at 90 ± 7 days post-surgery

    Treatment: deep brain stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Influencing Factors of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
Criteria questions
Built from NCT07031544, who can take part
Record updated
3 July 2025